LEGEND-HTN found benefit for patients treated with thiazide or thiazide-like diuretics compared to angiotensin-converting enzyme (ACE) inhibitors in terms of three main outcomes of interest, i.e., acute myocardial infarction (MI), hospitalization with heart failure, and stroke. Here, ACE is linked to heart failure.